PI3K-alpha inhibitors (Amgen)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePI3K-alpha inhibitors (Amgen)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors

TargetsPhosphatidylinositol 3 kinase alpha

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A